Does how often you eat make your blood glucose worse? CDE Gary Scheiner explains…

A new all-digital magazine, Insulin Nation , launched this month at http://www.insulinnation.com/ . The free interactive magazine will be available online and through...

Telcare's cellular-enabled blood glucose meter will automatically upload a user's test results to an online portal. Though people with diabetes are urged to keep...

Blood glucose monitoring meets Apple’s iPhone: our own Adam Brown test drives Sanofi/AgaMatrix’s new tiny smartphone glucose monitor, the iBGstar…

This winter we flew down to sunny Cape Town to attend the nineteenth official meeting of International Diabetes Federation (IDF).

What are going to be the big headlines for 2012? What will be the impact of Bydureon, the latest once-weekly drug for people with type 2 diabetes?

Eye diseases leading to blindness are consistently ranked among the greatest fears of people with diabetes, and the most common of these eye diseases is called diabetic...

In previous issues, we’ve documented the arduous journey of Orexigen’s anti-obesity drug Contrave through the regulatory process. In December, an FDA Advisory Committee...

diaTribe #21 - March 2010 - Qnexa: Treating Both Diabetes and Obesity diaTribe #24 - July 2010 - The Fate Of Vivus’ Weight Loss Drug Qnexa Rests With FDA plus editorial...

Self-monitoring of blood glucose (SMBG, i.e., fingersticks) and continuous glucose monitoring (CGM, i.e., wearing a sensor) sometimes seem like rival technologies in the...

(S)he said what?!?

According to a recent Apple report , over 425,000 mobile apps are now available in the App Store, with a staggering 200 million users and 15 billion downloads. And...

The Obesity Society's annual meeting has long been our favorite place to catch up on the basic science research behind this critical problem.

(S)he said what?!?

Here at diaTribe , we are constantly inspired by the huge number of organizations working to improve the lives of people with diabetes. On November 14, the IDF will host...

On June 16, FDA officials provided an update on its safety review of Takeda’s Actos (pioglitazone), announcing that going forward, prescribing information for Actos will...

(S)he said what?!?

While Lantus (Sanofi’s insulin glargine) is the current standard for basal insulins, companies are still investing significant efforts to develop even better long-acting...

Kelly reflects on her recent visit to Washington…

In late August, the European Commission approved Boehringer Ingelheim/Eli Lilly’s DPP-4 inhibitor, Tradjenta, for type 2 diabetes. Tradjenta (also known as Trajenta in...